Summit Trail Advisors LLC lifted its position in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 1.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,522 shares of the medical research company’s stock after buying an additional 192 shares during the […]
First Horizon Advisors Inc. lowered its holdings in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 99,339 shares of the medical research company’s stock after selling 2,343 shares during the quarter. First Horizon Advisors Inc.’s […]
Edwards Lifesciences Co. (NYSE:EW – Get Free Report) VP Jean-Luc M. Lemercier sold 14,400 shares of the business’s stock in a transaction on Wednesday, May 1st. The stock was sold at an average price of $84.21, for a total value of $1,212,624.00. Following the completion of the transaction, the vice president now directly owns 173,849 […]
Edwards Lifesciences Co. (NYSE:EW – Get Free Report) VP Jean-Luc M. Lemercier sold 14,400 shares of the firm’s stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $84.21, for a total transaction of $1,212,624.00. Following the sale, the vice president now directly owns 173,849 shares […]
StockNews.com upgraded shares of Edwards Lifesciences (NYSE:EW – Free Report) from a hold rating to a buy rating in a report released on Monday. Other analysts have also issued reports about the company. Stifel Nicolaus raised their price objective on Edwards Lifesciences from $83.00 to $85.00 and gave the company a hold rating in a […]